Christine Cassiano | Chief Communications Officer |
David Chang | President and Chief Executive Officer |
Rafael Amado | Executive Vice President-Research and Development and Chief Medical Officer |
Eric Schmidt | Chief Financial Officer |
Phil Nadeau | Cowen and Company |
Andrea Tan | Goldman Sachs |
Biren Amin | Jefferies |
Gavin Scott | JPMorgan |
Tyler Van Buren | Piper Sandler |
Aaron Welch | H.C. Wainwright |
Mark Breidenbach | Oppenheimer |
John Newman | Canaccord |
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to Allogene Therapeutics Second Quarter 2020 Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be aware that today's conference call is being recorded.